Bruker (BRKRP) EBT Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bruker | - | - | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,272.00 |
| Dec 31, 2025 | -1,067.00 |
| Sep 30, 2025 | -2,307.00 |
| Jun 30, 2025 | -731.00 |
| Mar 31, 2025 | -5.00 |
| Dec 31, 2024 | -1,281.00 |
| Sep 30, 2024 | -957.00 |
| Jun 30, 2024 | -673.00 |
| Mar 31, 2024 | 160.00 |
| Dec 31, 2023 | 723.00 |
| Sep 30, 2023 | 203.00 |
| Jun 30, 2023 | 161.00 |
| Mar 31, 2023 | 726.00 |
| Dec 31, 2022 | 226.00 |
| Sep 30, 2022 | 936.00 |
| Jun 30, 2022 | 455.00 |
| Mar 31, 2022 | 759.00 |
| Dec 31, 2021 | 94.00 |
| Sep 30, 2021 | 695.00 |
| Jun 30, 2021 | 923.00 |
| Mar 31, 2021 | 781.00 |
| Dec 31, 2020 | 2,789.00 |
| Sep 30, 2020 | 877.00 |
| Jun 30, 2020 | 96.00 |
| Mar 31, 2020 | -13.00 |
| Dec 31, 2019 | 997.00 |
| Sep 30, 2019 | 1,382.00 |
| Jun 30, 2019 | 247.00 |
| Mar 31, 2019 | 462.00 |
| Dec 31, 2018 | 1,114.00 |
| Sep 30, 2018 | 791.00 |
| Jun 30, 2018 | 191.00 |
| Mar 31, 2018 | 618.00 |
| Dec 31, 2017 | 779.00 |
| Sep 30, 2017 | -198.00 |
| Jun 30, 2017 | 269.00 |
| Mar 31, 2017 | 158.00 |
| Dec 31, 2016 | 244.00 |
| Sep 30, 2016 | 150.00 |
| Jun 30, 2016 | -344.00 |
| Mar 31, 2016 | 177.00 |
| Dec 31, 2015 | 2,059.00 |
| Sep 30, 2015 | -636.00 |
| Jun 30, 2015 | -479.00 |
| Mar 31, 2015 | -627.00 |